China Resources Fair Value
33
The fair market value of 3320.HK stock is 8.1 HKD. Relative to the market price of 4.96 HKD China Resources Pharmaceutical Group is undervalued by 63.4%
Eyestock's quantitative valuation approach is based on the method of estimating historical multipliers. To determine whether a stock is undervalued, we compare its current price to our estimated of fair value. The more undervalued a stock is, the more investment is profitable.
Fair Relative Value
China Resources Valuation
Current 3320.HK share ticker price is 4.96 HKD.
The fair value level of 8.1 HKD can be considered as an effective entry point for long-term investors to start investing in 3320.HK stock. For a more in-depth assessment, we provide a minimum value that can be used to increase a stock position and a maximum one that can be used to reduce it.
Price chart is not available
Current market price
Current price is 63% lower its fair value
Current price is 27% lower its minimum value
Current price is 149% lower its maximum value
Market price:
3320.HK stock is greatly undervalued
It means the current price may concern as a Low Risk Entry Point
China Resources Pharmaceutical Group Ltd Stock Valuation Calculator
How do we value a stock?
As fair value, we use the product of the median Price-to-earnings ratios at the end of each reporting period for the last 5 years and earnings per share for the last 12 months. By analogy with the fair value, we calculate the maximum and minimum ones using the corresponding P/E extremums.
1
Maximum P/E over 5 years
11.62
2
Median P/E over 5 years
7.64
3
Minimum P/E over 5 years
5.92
4
Earning per share (last 12 months)
1.06 HKD
Maximum value
1
x
4
=
12.33 HKD
Fair value
2
x
4
=
8.1 HKD
Minimum value
3
x
4
=
6.28 HKD
China Resources Pharmaceutical Group Ltd price metrics
-9.5
Annual return (geometric mean)
39.1
Risk (standard deviation) of returns
β
0.9
Beta (volatility compared to market)